Precigen, Inc. (NASDAQ:PGEN) Shares Bought by Geode Capital …

Jan 7, 2025 · Precigen Trading Up 5.8 %. Shares of NASDAQ:PGEN opened at $1.27 on Tuesday. The stock has a market capitalization of $371.94 million, a PE ratio of -2.31 and a …

$1.27
OFF

Precigen, Inc. (NASDAQ:PGEN) Shares Bought By Geode Capital …

2 weeks from now

Jan 7, 2025 · Precigen Trading Up 5.8 %. Shares of NASDAQ:PGEN opened at $1.27 on Tuesday. The stock has a market capitalization of $371.94 million, a PE ratio of -2.31 and a …

etfdailynews.com

$1.27
OFF

Precigen, Inc. (NASDAQ:PGEN) Shares Bought By Geode Capital …

2 weeks from now

Jan 7, 2025 · Read Our Latest Report on Precigen. Precigen Stock Up 5.8 %. Shares of NASDAQ PGEN opened at $1.27 on Tuesday. The stock has a market capitalization of $371.94 million, …

defenseworld.net

$64
OFF

A US$64m Market Cap Addition Is Just What Precigen, Inc.

2 weeks from now

Dec 1, 2021 · Insiders who bought Precigen, Inc. ( NASDAQ:PGEN ) stock in the last 12 months were richly rewarded last week. The...

yahoo.com

$3075000
OFF

Precigen (NASDAQ:PGEN) Receives Market Outperform Rating …

2 weeks from now

1 day ago · Geode Capital Management LLC now owns 3,246,508 shares of the biotechnology company's stock valued at $3,075,000 after buying an additional 149,829 shares in the last …

marketbeat.com

$318
OFF

Precigen's SWOT Analysis: Gene Therapy Stock Focuses On RRP …

2 weeks from now

12 hours ago · Precigen, Inc. (NASDAQ: PGEN), a biotechnology company specializing in gene and cell therapies with a market capitalization of $318 million, has recently undergone …

investing.com

FAQs about Precigen, Inc. (NASDAQ:PGEN) Shares Bought by Geode Capital … Coupon?

Does Geode Capital Management own precigen (PGen)?

Geode Capital Management LLC lifted its position in Precigen, Inc. (NASDAQ:PGEN – Free Report) by 4.8% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 3,246,508 shares of the biotechnology company’s stock after buying an additional 149,829 shares during the period. ...

Who owns precigen?

Top institutional shareholders of Precigen include Iridian Asset Management LLC CT (1.49%), Geode Capital Management LLC (1.28%), State Street Corp (1.14%) and Charles Schwab Investment Management Inc. (0.48%). ...

Should you buy precigen (precigen) stock?

Two investment analysts have rated the stock with a sell rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat, Precigen currently has an average rating of “Hold” and an average price target of $7.00. View Our Latest Analysis on Precigen (Free Report) ...

Should you buy precigen (PGen – research report)?

Analyst Jason Butler from JMP Securities reiterated a Buy rating on Precigen (PGEN – Research Report) and keeping the price target at $5.00. Jason Butler has given his Buy rating due to a combination of factors surrounding Precigen’s strategic advancements and preparations. ...

Who is precigen (PGen)?

Begin your TipRanks Premium journey today. Precigen (PGEN) Company Description: Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. ...

Does FMR LLC own precigen?

Finally, FMR LLC grew its holdings in shares of Precigen by 26.4% in the 3rd quarter. FMR LLC now owns 345,204 shares of the biotechnology company’s stock worth $327,000 after acquiring an additional 72,033 shares during the last quarter. Institutional investors and hedge funds own 33.51% of the company’s stock. ...